These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15835269)

  • 21. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased dysferlin expression in Duchenne muscular dystrophy.
    Vontzalidis A; Terzis G; Manta P
    Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Dysferlin Direct Interactions with Putative Repair Proteins Links Apoptotic Signaling to Ca
    Drescher DG; Drescher MJ; Selvakumar D; Annam NP
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction.
    Yamaji S; Suzuki A; Sugiyama Y; Koide Y; Yoshida M; Kanamori H; Mohri H; Ohno S; Ishigatsubo Y
    J Cell Biol; 2001 Jun; 153(6):1251-64. PubMed ID: 11402068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
    Bönnemann CG; Finkel RS
    Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amyloidosis in muscular dystrophy].
    Carl M; Röcken C; Spuler S
    Pathologe; 2009 May; 30(3):235-9. PubMed ID: 19326120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affixin activates Rac1 via betaPIX in C2C12 myoblast.
    Matsuda C; Kameyama K; Suzuki A; Mishima W; Yamaji S; Okamoto H; Nishino I; Hayashi YK
    FEBS Lett; 2008 Apr; 582(8):1189-96. PubMed ID: 18325335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction.
    Yamaji S; Suzuki A; Kanamori H; Mishima W; Yoshimi R; Takasaki H; Takabayashi M; Fujimaki K; Fujisawa S; Ohno S; Ishigatsubo Y
    J Cell Biol; 2004 May; 165(4):539-51. PubMed ID: 15159419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
    Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S
    Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysferlin expression in tubular aggregates: their possible relationship to endoplasmic reticulum stress.
    Ikezoe K; Furuya H; Ohyagi Y; Osoegawa M; Nishino I; Nonaka I; Kira J
    Acta Neuropathol; 2003 Jun; 105(6):603-9. PubMed ID: 12664320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro dysferlin expression in human muscle satellite cells.
    De Luna N; Gallardo E; Illa I
    J Neuropathol Exp Neurol; 2004 Oct; 63(10):1104-13. PubMed ID: 15535137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism.
    Cenacchi G; Fanin M; De Giorgi LB; Angelini C
    J Clin Pathol; 2005 Feb; 58(2):190-5. PubMed ID: 15677541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy.
    Inoue M; Wakayama Y; Kojima H; Shibuya S; Jimi T; Oniki H; Nishino I; Nonaka I
    Tohoku J Exp Med; 2006 Jun; 209(2):109-16. PubMed ID: 16707852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
    Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.
    de Morrée A; Hensbergen PJ; van Haagen HH; Dragan I; Deelder AM; 't Hoen PA; Frants RR; van der Maarel SM
    PLoS One; 2010 Nov; 5(11):e13854. PubMed ID: 21079765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
    Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
    PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle.
    Azakir BA; Di Fulvio S; Therrien C; Sinnreich M
    PLoS One; 2010 Apr; 5(4):e10122. PubMed ID: 20405035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysferlin is a plasma membrane protein and is expressed early in human development.
    Anderson LV; Davison K; Moss JA; Young C; Cullen MJ; Walsh J; Johnson MA; Bashir R; Britton S; Keers S; Argov Z; Mahjneh I; Fougerousse F; Beckmann JS; Bushby KM
    Hum Mol Genet; 1999 May; 8(5):855-61. PubMed ID: 10196375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.